About Jon Saxe
Form D filings for Aether Therapeutics in 2024 list Jon Saxe as executive officer and director.
Jon Saxe first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jon Saxe in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jon Saxe works with at each company, as listed on that company's latest Form D.
Aether Therapeutics Inc. · Form D, Jan 19, 2024